Nab-Paclitaxel/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of nab-paclitaxel and pembrolizumab that can be used for the treatment of recurrent and metastatic hormone receptor-negative, HER-2 (EGFR2; ErbB2)-negative and PD-L1-positive breast cancer.

**Synonyms:** - Abraxane/Keytruda - Albumin-bound Paclitaxel/Pembrolizumab Regimen - Nab-Paclitaxel-Pembrolizumab - Nab-Paclitaxel-Pembrolizumab Regimen - Nab-Paclitaxel/Pembrolizumab - Pembrolizumab Plus Nab-Paclitaxel - Pembrolizumab-Nab-Paclitaxel - Pembrolizumab/Nab-Paclitaxel - Pembrolizumab/Nab-Paclitaxel Regimen - nab-Paclitaxel and Pembrolizumab